Neonc Technologies Holdings Inc (NTHI)

$12.00 -0.11 (-0.91%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 9,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and s...

Industry: Biotechnology
Sector: Healthcare
Phone: 310-663-7831
Address:
23975 Park Sorrento, Suite 205, Calabasas, United States
StockScanners
StockScanners Sep. 14 at 1:01 AM
$NTHI reached 10.92
1 · Reply
Spiderman1979
Spiderman1979 Sep. 12 at 9:21 PM
$NTHI
0 · Reply
StockScanners
StockScanners Sep. 11 at 2:00 AM
$NTHI keep watch if this holds above 8.80
0 · Reply
DylanGFM
DylanGFM Sep. 10 at 4:35 PM
$NTHI now this in the other hand might keep grinding up nice and easy like it did. Those low volume easy moves up usually have a nice spike before they sell!
1 · Reply
theshortsqueezer2022
theshortsqueezer2022 Sep. 10 at 4:09 PM
$NTHI bullish AF
0 · Reply
jmp470
jmp470 Sep. 5 at 4:08 PM
$NTHI taking some profits off the table here
1 · Reply
jmp470
jmp470 Sep. 5 at 2:07 PM
$NTHI Patience pays off! Not time to sell, yet.
0 · Reply
Goatcheese
Goatcheese Aug. 27 at 4:46 PM
$NTHI any positive catalyst and this jumps 30%
1 · Reply
jmp470
jmp470 Aug. 26 at 3:13 PM
$NTHI Just getting started!
0 · Reply
Goatcheese
Goatcheese Aug. 21 at 8:08 PM
$NTHI up this week 👀
0 · Reply
Latest News on NTHI
Blue Gold Appoints Quazar's Sameer Salgar to Advisory Board to Establish UAE Ties and Guide Digital Gold Strategy

Sep 10, 2025, 9:40 AM EDT - 6 days ago

Blue Gold Appoints Quazar's Sameer Salgar to Advisory Board to Establish UAE Ties and Guide Digital Gold Strategy

BGL

NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer

Sep 10, 2025, 9:00 AM EDT - 6 days ago

NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer

NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board

Aug 25, 2025, 9:00 AM EDT - 22 days ago

NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board

NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation

Aug 11, 2025, 9:00 AM EDT - 5 weeks ago

NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation

NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia

Aug 7, 2025, 9:00 AM EDT - 5 weeks ago

NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia

NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer

Aug 4, 2025, 9:00 AM EDT - 6 weeks ago

NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer

NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors

Jul 30, 2025, 9:00 AM EDT - 6 weeks ago

NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors

CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc.

Jul 23, 2025, 10:53 AM EDT - 7 weeks ago

CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc.

NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform

Jul 8, 2025, 9:00 AM EDT - 2 months ago

NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

Jun 6, 2025, 9:00 AM EDT - 3 months ago

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

Apr 15, 2025, 8:05 AM EDT - 5 months ago

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

Apr 14, 2025, 8:05 AM EDT - 5 months ago

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

Apr 10, 2025, 8:05 AM EDT - 5 months ago

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

Apr 8, 2025, 4:05 PM EDT - 5 months ago

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

Mar 31, 2025, 8:05 AM EDT - 6 months ago

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

Mar 27, 2025, 8:05 AM EDT - 6 months ago

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors

Mar 25, 2025, 8:45 AM EDT - 6 months ago

NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors

NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors

Mar 25, 2025, 8:15 AM EDT - 6 months ago

NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

Jan 4, 2025, 12:30 AM EST - 9 months ago

U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings

AERO CAPS CRGT FBGL FLOC INLF INR

NeOnc Technologies Receives Pharma Tech Outlook's Top Drug Delivery Platform Award for 2024

Oct 7, 2024, 11:00 AM EDT - 1 year ago

NeOnc Technologies Receives Pharma Tech Outlook's Top Drug Delivery Platform Award for 2024

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate

Aug 5, 2024, 11:00 AM EDT - 1 year ago

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate

NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation

Jul 16, 2024, 11:15 AM EDT - 1 year ago

NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status

Jun 26, 2024, 4:39 PM EDT - 1 year ago

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status

NeOnc Technologies Wins California Investment Forum's Breakthrough Medical Technology Achievement Award

May 15, 2024, 11:00 AM EDT - 1 year ago

NeOnc Technologies Wins California Investment Forum's Breakthrough Medical Technology Achievement Award

NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10

May 9, 2024, 5:30 PM EDT - 1 year ago

NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

Mar 30, 2024, 1:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

BOLD MMA MNDR NTCL ROTR UBXG WAY

U.S. IPO Weekly Recap: Small Japanese Lists In The US As Insurer Aspen Holdings Joins The IPO Pipeline

Dec 25, 2023, 9:05 AM EST - 1 year ago

U.S. IPO Weekly Recap: Small Japanese Lists In The US As Insurer Aspen Holdings Joins The IPO Pipeline

LGCB MAMO LZMH

Neonc Technologies Seeks U.S. IPO For Brain Cancer Treatment Pipeline

Dec 20, 2023, 2:38 PM EST - 1 year ago

Neonc Technologies Seeks U.S. IPO For Brain Cancer Treatment Pipeline

StockScanners
StockScanners Sep. 14 at 1:01 AM
$NTHI reached 10.92
1 · Reply
Spiderman1979
Spiderman1979 Sep. 12 at 9:21 PM
$NTHI
0 · Reply
StockScanners
StockScanners Sep. 11 at 2:00 AM
$NTHI keep watch if this holds above 8.80
0 · Reply
DylanGFM
DylanGFM Sep. 10 at 4:35 PM
$NTHI now this in the other hand might keep grinding up nice and easy like it did. Those low volume easy moves up usually have a nice spike before they sell!
1 · Reply
theshortsqueezer2022
theshortsqueezer2022 Sep. 10 at 4:09 PM
$NTHI bullish AF
0 · Reply
jmp470
jmp470 Sep. 5 at 4:08 PM
$NTHI taking some profits off the table here
1 · Reply
jmp470
jmp470 Sep. 5 at 2:07 PM
$NTHI Patience pays off! Not time to sell, yet.
0 · Reply
Goatcheese
Goatcheese Aug. 27 at 4:46 PM
$NTHI any positive catalyst and this jumps 30%
1 · Reply
jmp470
jmp470 Aug. 26 at 3:13 PM
$NTHI Just getting started!
0 · Reply
Goatcheese
Goatcheese Aug. 21 at 8:08 PM
$NTHI up this week 👀
0 · Reply
jmp470
jmp470 Aug. 4 at 4:54 PM
$NTHI is this a closet runner. Will hit peoples scanner after a 10 / 20 % day…. Building a nice base down here, just keep adding shares when you can.
1 · Reply
Henry18
Henry18 Aug. 4 at 2:47 PM
$NTHI Adding here daily for boom or bust.
0 · Reply
StupidestTrader
StupidestTrader Aug. 1 at 2:12 PM
$NTHI are we in the hold and wait phase right now? Just confirm and I'll hold tight.
1 · Reply
a_traderjoesmarket
a_traderjoesmarket Jul. 31 at 1:57 AM
$NTHI
0 · Reply
gravetrencher
gravetrencher Jul. 30 at 11:42 PM
$NTHI excited on this one, accumulating for a couple of days with the short attack. See you on the moon.
0 · Reply
a_traderjoesmarket
a_traderjoesmarket Jul. 30 at 8:10 PM
$NTHI These guys really putting themselves out there with this one. Very interesting 🤔
1 · Reply
MiSi23
MiSi23 Jul. 30 at 7:58 PM
$NTHI New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards https://www.accessnewswire.com/newsroom/en/publishing-and-media/new-to-the-street-signs-neonc-technologies-holdings-inc.-nasdaq-nthi-to-12-par-1054943
0 · Reply
Goatcheese
Goatcheese Jul. 30 at 6:38 PM
$NTHI plans laid out, but no significant price action … yet
0 · Reply
a_traderjoesmarket
a_traderjoesmarket Jul. 30 at 6:13 PM
$NTHI Dips getting bought up
0 · Reply
jmp470
jmp470 Jul. 30 at 4:13 PM
$NTHI this little ticker caught my eye. bought 200 shares to see where it goes. will scale up / out depending on developments.
0 · Reply
StupidestTrader
StupidestTrader Jul. 30 at 3:55 PM
I'm still holding $NTHI I'm in the red as my avg is 5.31
0 · Reply
a_traderjoesmarket
a_traderjoesmarket Jul. 30 at 3:12 PM
$NTHI News from this morning. They might be planning something big
2 · Reply